Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiography, Thoracic | 1 | 2019 | 65 | 0.670 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 449 | 0.650 |
Why?
|
| Intensive Care Units | 1 | 2019 | 222 | 0.610 |
Why?
|
| Critical Care | 1 | 2019 | 213 | 0.590 |
Why?
|
| Antipsychotic Agents | 2 | 2004 | 232 | 0.230 |
Why?
|
| Dibenzothiazepines | 1 | 2002 | 10 | 0.210 |
Why?
|
| Hypertriglyceridemia | 1 | 2002 | 13 | 0.210 |
Why?
|
| Hyperglycemia | 1 | 2002 | 79 | 0.200 |
Why?
|
| Methadone | 2 | 2013 | 172 | 0.190 |
Why?
|
| Bipolar Disorder | 1 | 2002 | 192 | 0.180 |
Why?
|
| Cocaine-Related Disorders | 2 | 2014 | 205 | 0.180 |
Why?
|
| Mental Disorders | 1 | 2004 | 396 | 0.170 |
Why?
|
| Societies, Medical | 1 | 2019 | 175 | 0.160 |
Why?
|
| Faculty, Medical | 2 | 2009 | 89 | 0.140 |
Why?
|
| Psychiatry | 2 | 2009 | 105 | 0.140 |
Why?
|
| Cohort Studies | 1 | 2019 | 1422 | 0.130 |
Why?
|
| Hospitals, Teaching | 1 | 2014 | 53 | 0.120 |
Why?
|
| Erythrocyte Transfusion | 1 | 2014 | 46 | 0.120 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2014 | 18 | 0.120 |
Why?
|
| Amines | 1 | 2014 | 40 | 0.120 |
Why?
|
| Education, Medical, Continuing | 1 | 2014 | 68 | 0.120 |
Why?
|
| Sertraline | 1 | 2014 | 46 | 0.120 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2014 | 65 | 0.110 |
Why?
|
| Diltiazem | 1 | 2013 | 10 | 0.110 |
Why?
|
| Verapamil | 1 | 2013 | 21 | 0.110 |
Why?
|
| Naloxone | 1 | 2013 | 78 | 0.110 |
Why?
|
| Calcium Channel Blockers | 1 | 2013 | 62 | 0.110 |
Why?
|
| Disulfiram | 1 | 2010 | 10 | 0.090 |
Why?
|
| Opiate Substitution Treatment | 1 | 2010 | 89 | 0.080 |
Why?
|
| Depression | 1 | 2014 | 568 | 0.080 |
Why?
|
| Benzhydryl Compounds | 1 | 2009 | 67 | 0.080 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2009 | 94 | 0.080 |
Why?
|
| Humans | 11 | 2019 | 49974 | 0.080 |
Why?
|
| Drug Therapy, Combination | 2 | 2014 | 377 | 0.070 |
Why?
|
| Methamphetamine | 1 | 2009 | 200 | 0.070 |
Why?
|
| Career Mobility | 1 | 2007 | 25 | 0.070 |
Why?
|
| Schools, Medical | 1 | 2007 | 69 | 0.070 |
Why?
|
| Clinical Competence | 1 | 2009 | 393 | 0.060 |
Why?
|
| Attitude of Health Personnel | 1 | 2009 | 347 | 0.060 |
Why?
|
| Prolactin | 1 | 2004 | 44 | 0.060 |
Why?
|
| Risperidone | 1 | 2004 | 25 | 0.060 |
Why?
|
| Internship and Residency | 1 | 2009 | 443 | 0.050 |
Why?
|
| Erectile Dysfunction | 1 | 2004 | 85 | 0.050 |
Why?
|
| Self Report | 2 | 2013 | 196 | 0.050 |
Why?
|
| Female | 6 | 2014 | 26472 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2013 | 1376 | 0.040 |
Why?
|
| Adult | 5 | 2014 | 13236 | 0.040 |
Why?
|
| Male | 6 | 2014 | 25241 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2002 | 477 | 0.030 |
Why?
|
| Middle Aged | 4 | 2014 | 12069 | 0.030 |
Why?
|
| GABA Agonists | 1 | 2014 | 15 | 0.030 |
Why?
|
| Adolescent | 2 | 2004 | 6356 | 0.030 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2014 | 41 | 0.030 |
Why?
|
| Risk Factors | 1 | 2002 | 3613 | 0.030 |
Why?
|
| Calcium Channels, L-Type | 1 | 2013 | 67 | 0.030 |
Why?
|
| Medication Adherence | 1 | 2014 | 128 | 0.030 |
Why?
|
| Patient Compliance | 1 | 2014 | 230 | 0.030 |
Why?
|
| Drug Interactions | 1 | 2013 | 206 | 0.030 |
Why?
|
| Recurrence | 1 | 2014 | 652 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2014 | 681 | 0.030 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2013 | 169 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 637 | 0.030 |
Why?
|
| Cocaine | 1 | 2010 | 170 | 0.020 |
Why?
|
| Neuropsychology | 1 | 2009 | 8 | 0.020 |
Why?
|
| Specialty Boards | 1 | 2009 | 24 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2010 | 224 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2009 | 144 | 0.020 |
Why?
|
| Quality Assurance, Health Care | 1 | 2009 | 149 | 0.020 |
Why?
|
| Data Collection | 1 | 2009 | 279 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2009 | 699 | 0.020 |
Why?
|
| Opioid-Related Disorders | 1 | 2010 | 381 | 0.020 |
Why?
|
| Curriculum | 1 | 2009 | 401 | 0.020 |
Why?
|
| Young Adult | 1 | 2014 | 3958 | 0.010 |
Why?
|
| Penile Erection | 1 | 2004 | 22 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 2004 | 88 | 0.010 |
Why?
|
| Affect | 1 | 2004 | 99 | 0.010 |
Why?
|
| Testosterone | 1 | 2004 | 139 | 0.010 |
Why?
|
| Arkansas | 1 | 2009 | 1977 | 0.010 |
Why?
|
| Schizophrenia | 1 | 2004 | 256 | 0.010 |
Why?
|
| United States | 1 | 2007 | 4860 | 0.010 |
Why?
|
| Aged | 1 | 2004 | 9310 | 0.010 |
Why?
|